Novo Nordisk (NVO) said Thursday shareholders at its annual general meeting approved a total 2025 dividend of 11.70 Danish kroner per share ($1.81), including a final dividend of 7.95 Danish kroner to be paid in March.
Shareholders re-elected Lars Rebien Sorensen as chair and authorized the company to repurchase up to 10% of its share capital. Investors also approved an extension of the board's authorization to increase share capital until April 2028, according to the company.
Shares of Novo Nordisk were up 1.6% in Thursday trading.
Price: 36.91, Change: +0.58, Percent Change: +1.60
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments